iBio, Inc.

IBIO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$6-$5-$5-$4
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$1$0$1-$0
Other Non-Cash$0-$0-$0$0
Operating Cash Flow-$6-$5-$3-$4
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$21$0$0-$0
Investing Cash Flow-$21$0-$0-$0
Financing Activities
Debt Repay.-$0-$0-$0-$0
Stock Issued$47$2$1$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$6$0$0
Financing Cash Flow$47$8$1-$0
Forex Effect-$0$0$0$0
Net Chg. in Cash$20$4-$2-$4
Supplemental Information
Beg. Cash$9$5$7$11
End Cash$28$9$5$7
Free Cash Flow-$6-$5-$3-$4
iBio, Inc. (IBIO) Financial Statements & Key Stats | AlphaPilot